ORION PHARMA A/S

CVR: 20601116

Growing 6% p.a.Small companyWell-established (73 yrs)Profitable

Secondary names: ERCOPHARM A/S

Active

The financial health of ORION PHARMA A/S appears stable, with a notable increase in revenue and profit in 2024, reaching 309 million DKK and 10.9 million DKK, respectively. Over the past four years, revenue has shown a growth trend, rising from 214 million DKK in 2022 to 309 million DKK in 2024, while profit has also improved from 4.5 million DKK in 2021 to nearly 11 million DKK in 2024. However, equity has decreased from 51.7 million DKK in 2023 to 32 million DKK in 2024, raising concerns about the company's financial stability. Despite these challenges, ORION PHARMA maintains a solid position within the pharmaceutical wholesale industry, leveraging its growing revenue stream to enhance profitability.

AI-generated summary

Overview

Company type: A/S; Aktieselskab
Address: Ørestads Boulevard 73, 2300 København S; KØBENHAVN; 2300 København S; Find nearby companies
Founded: 16.2.1953

Details

Industry: Engroshandel med medicinalvarer og sygeplejeartikler; Code: 464610
Employees: 29 employees; 28 FTE; (2018)
Capital: 3.000.000 kr.

Contact

Advertising protected

Phone: Log in to see
Website: www.orionpharma.dk

Purpose

Selskabets formål er at drive handel, derunder import og eksport samt agenturvirksomhed med kemiske og pharmaceutiske produkter, medicinalvarer, artikler til sådanne frembringelser.